Results 91 to 100 of about 4,521 (190)

Immune persistence and safety of the AS01<sub>E</sub>-adjuvanted respiratory syncytial virus prefusion F protein-based vaccine in adults 50-59 years of age, including at-increased-risk adults: A randomized controlled trial. [PDF]

open access: yesHum Vaccin Immunother
Ferguson M   +20 more
europepmc   +1 more source

Role of the multiple telomeric repeat arrays in integration, persistence, and efficacy of the commercial CVI988 vaccine. [PDF]

open access: yesmSphere
Bertzbach LD   +7 more
europepmc   +1 more source

An Overview of Avian Vaccination Options in Zoological Collections in Europe. [PDF]

open access: yesVet Sci
Leus J   +5 more
europepmc   +1 more source

Use of the Workbook Method to estimate the prevalence of chronic hepatitis B infections in the European Union and European Economic Area, 2022. [PDF]

open access: yesEuro Surveill
Canabarro APF   +40 more
europepmc   +1 more source

A Field Experiment of Marek's Disease Vaccine

open access: yesJournal of the Japan Veterinary Medical Association, 1973
S. YAMADA   +9 more
openaire   +2 more sources

Trained immunity in cancer and autoimmunity: a double-edged sword in immune memory reprogramming. [PDF]

open access: yesFront Immunol
Salari N   +5 more
europepmc   +1 more source

A recombinant Marek's disease vaccine candidate provides complete protection against infectious bursal disease virus and H9 subtype avian influenza virus in chickens. [PDF]

open access: yesJ Virol
Fan W   +16 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy